Latest Transformation News

Streamplay Studio Limited has voluntarily suspended its shares on the ASX pending a significant announcement about a new gaming platform agreement, signaling a potentially pivotal development for the company.

Australian Vintage outlines a strategic turnaround with innovative product launches and a key acquisition, aiming to reverse declining sales and improve cash flow in FY2026.

BSP Financial Group reported a 17% rise in net profit and a 16% dividend increase for 2024, while advancing key digital and SME banking initiatives across the South Pacific.

Dateline Resources has revised its gold price assumption to US$2,900/oz for the Colosseum Gold Project, significantly enhancing the project's economic outlook ahead of its Bankable Feasibility Study.

Bendigo and Adelaide Bank reported a 7.8% decline in cash earnings for 3Q25, reflecting lower other income and a slight dip in net interest income, while completing its Rural Bank system migration.

HighCom Limited has landed a significant A$2.6 million order from the Australian Department of Defence to supply Counter Small Uncrewed Aerial Systems, marking a strategic expansion into counter-drone technology.

SKS Technologies has been awarded a $100 million contract to fit out electrical infrastructure for a new data centre building in Melbourne, marking a significant boost to its project pipeline and work on hand.

Resource Mining Corporation has raised $2 million through a share placement to accelerate copper-gold exploration in Tanzania, with strong backing from directors including Chairman Asimwe Kabunga.

West Coast Silver has completed a transformative acquisition of the Elizabeth Hill Silver Project and secured $3 million in fresh capital, setting the stage for a new era focused on high-grade silver exploration in the Pilbara.

Ventia Services Group Limited delivered strong financial results for 2024, highlighted by a 12.8% rise in NPATA and a record 92% contract renewal rate, while reaffirming growth guidance despite ongoing ACCC proceedings.

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in treating FSGS kidney disease has passed its sixth independent safety review with no concerns, reinforcing the drug’s promising safety profile.

Zelira Therapeutics has published full results from a Phase I study showing its cannabinoid-based therapy ZLT-L-007 significantly outperforms Lyrica® in managing diabetic neuropathy pain and related symptoms.